Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 143.00
Ask: 145.00
Change: -4.00 (-2.76%)
Spread: 2.00 (1.399%)
Open: 143.00
High: 145.00
Low: 141.00
Prev. Close: 145.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Xaar plc - Commercial partnership with Quantica

5 Jul 2023 09:00

RNS Number : 9635E
Xaar PLC
05 July 2023
 

5 July 2023

 

Xaar plc

 

Commercial partnership with Quantica

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, and Quantica GmbH ("Quantica"), the multi-material 3D printing firm, have signed an exclusive commercial partnership to manufacture Quantica's NovoJet printheads, enabling ultra high viscosity printing for 2D and 3D printing applications. This partnership combines Xaar's expertise in inkjet printhead manufacturing with Quantica's ultra high viscosity printhead technology.

 

Manufacturing will take place at Xaar's high-tech facility in Huntingdon, with both companies expecting the initial NovoJet printheads to be shipping in Quantica's first 3D printers from the end of 2023. 

 

The agreement also gives Xaar commercial access to Quantica's IP in the jetting of highly viscous materials at up to 400cP at jetting temperature. This will complement Xaar's existing printheads and ImagineX technology portfolio which already enable jetting up to 100cP - far beyond other printheads available today.

 

Xaar will now offer the widest capability in printing high-performance materials to its OEM customers, meeting the opportunities for advanced manufacturing applications across electronics, display, industrial coating, adhesive and life-science sectors.

 

Founded in 2018 in Berlin, Quantica has dedicated its research and development efforts to both the novel NovoJet printhead technology and advanced multi-material 3D printers. By partnering with Xaar, a leader in inkjet printhead manufacturing, Quantica will further focus on the development of its 3D printing systems for applications in dental, medical, electronics, R&D, and more.

 

Graham Tweedale, Xaar's Chief Operation Officer, said:

 

"As we continue to accelerate our strategy the combination of our existing ImagineX technologies with the capability offered by Quantica's IP will ensure Xaar offers the widest range of solutions in jetting highly viscous materials."

 

Ramon Borrell, Chief Technology Officer for Quantica, said:

 

"Xaar is widely recognised for the quality of its printheads, and this agreement enables us to focus on delivering the roadmap of innovative NovoJet 3D printers for high performance multi-material parts with full confidence the printheads will deliver for our customers and partners."

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEZLFBXDLEBBF
Date   Source Headline
7th Jun 201210:10 amRNSHolding(s) in Company
1st Jun 20129:24 amRNSDirector Declaration
31st May 20124:54 pmRNSTotal Voting Rights
22nd May 20124:54 pmRNSResult of AGM
17th May 20121:21 pmRNSHolding(s) in Company
4th May 20127:00 amRNSNotice of AGM
3rd May 20124:35 pmRNSHolding(s) in Company
2nd May 20123:12 pmRNSGrant of Options
1st May 20129:38 amRNSTotal Voting Rights
25th Apr 20125:21 pmRNSHolding(s) in Company
25th Apr 201211:26 amRNSDirector/ PDMR Shareholding
23rd Apr 20127:00 amRNSDirector/PDMR Shareholding
19th Apr 20127:00 amRNSAnnual Information Update
19th Apr 20127:00 amRNSInterim Management Statement
16th Apr 20126:13 pmRNSDirector/PDMR Shareholding - Replacement
13th Apr 20128:54 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSIssue of Options
30th Mar 20125:39 pmRNSTotal Voting Rights
19th Mar 20127:00 amRNSFinal Results
15th Mar 20127:00 amRNSHolding(s) in Company
9th Mar 20124:00 pmRNSHolding(s) in Company
1st Mar 20128:30 amRNSHolding(s) in Company
29th Feb 20128:48 amRNSHolding(s) in Company
28th Feb 20127:00 amRNSChange of 2011 Results Announcement Date
20th Feb 20125:33 pmRNSHolding(s) in Company
20th Feb 20125:24 pmRNSHolding(s) in Company
24th Jan 20126:05 pmRNSHolding(s) in Company
24th Jan 20127:00 amRNSChina Staff Changes
19th Jan 20127:00 amRNSTrading Statement
23rd Dec 20117:02 amRNSTotal Voting Rights
23rd Dec 20117:01 amRNSBlocklisting Interim Review
23rd Dec 20117:00 amRNSIssue of Options
24th Nov 20119:58 amRNSHolding(s) in Company
18th Nov 20113:23 pmRNSBlocklisting Interim Review
17th Nov 20115:31 pmRNSHolding(s) in Company
21st Oct 201112:06 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSInterim Management Statement
11th Oct 201112:24 pmRNSHolding(s) in Company
4th Oct 201112:59 pmRNSTotal Voting Rights
30th Sep 20119:04 amRNSDirector/PDMR Shareholding
26th Sep 20115:50 pmRNSHolding(s) in Company
26th Aug 20115:21 pmRNSHolding(s) in Company
23rd Aug 20114:14 pmRNSDirector/PDMR Shareholding
18th Aug 20111:55 pmRNSHalf Yearly Report - Replacement
18th Aug 20117:00 amRNSInterim Management Statement
5th Aug 20112:59 pmRNSAdditional Listing
7th Jul 20117:00 amRNSInterim Trading Update
21st Jun 20114:34 pmRNSHolding(s) in Company
15th Jun 20117:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.